Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Gilead Sciences (NQ:GILD)

138.99 -3.10 (-2.18%)

Official Closing Price Updated: 4:15 PM EDT, Apr 10, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	4,418,837
Open	142.38
Bid (Size)	138.47 (100)
Ask (Size)	142.00 (200)
Prev. Close	142.09
Today's Range	138.45 - 142.38
52wk Range	93.37 - 157.29
Shares Outstanding	1,253,809,440
Dividend Yield	2.27%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Gilead Expands Partnership With Tempus AI To Power Cancer Discoveries ↗

April 10, 2026

Tempus AI (TEM) shares up 3.6% on expanded Gilead oncology deal. Explore technical support levels, ALERT trial success, and analyst ratings.

Via Benzinga

Gilead Sciences Solidifies Oncology Future with $5 Billion Acquisition of ADC Innovator Tubulis

April 09, 2026

In a bold move to dominate the rapidly evolving cancer treatment landscape, Gilead Sciences (Nasdaq: GILD) announced on April 7, 2026, its acquisition of the German biotech firm Tubulis for a total...

Via MarketMinute

Performance

YTD	+14.3%	+14.3%
1 Month	-4.8%	-4.8%
3 Month	+14.8%	+14.8%
6 Month	+18.6%	+18.6%
1 Year	+37.1%	+37.1%

More News

Gilead Expands Tempus AI Partnership To Boost Oncology Pipeline ↗

April 09, 2026

Via Benzinga

Gilead Acquisition Spree Continues With $3 Billion Tubulis Deal ↗

April 07, 2026

Via Benzinga

GILEAD SCIENCES INC (NASDAQ:GILD): A Durable Dividend Stock for Income Investors ↗

March 10, 2026

Via Chartmill

Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline

April 07, 2026

From Gilead Sciences, Inc.

Via Business Wire

Gilead Extends Tender Offer for Arcellx as Biotech M&A Sentiment Faces a Reality Check

April 06, 2026

Via MarketMinute

Gilead Extends Tender Offer to Acquire Arcellx

April 01, 2026

From Gilead Sciences, Inc.

Via Business Wire

Gilead Sciences's Q1 2026 Earnings: What to Expect

April 01, 2026

Via Barchart.com

Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution

March 31, 2026

Via MarketMinute

Options Action: Naked Put Trade Ideas for March 31

March 31, 2026

Via Barchart.com

Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge ↗

March 30, 2026

Via The Motley Fool

$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today ↗

March 30, 2026

Via Benzinga

Gilead Powers Up Its Inflammation Pipeline With Over $1.5 Billion Acquisition ↗

March 24, 2026

Via Benzinga

Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases

March 23, 2026

From Gilead Sciences, Inc.

Via Business Wire

The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips

March 19, 2026

Via MarketMinute

3 Reasons to Avoid GILD and 1 Stock to Buy Instead

March 18, 2026

Via StockStory

This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal ↗

March 16, 2026

Via The Motley Fool

Movers and shakers in today's after-hours session for S&P500 stocks? ↗

March 16, 2026

Via Chartmill

2 Mega-Cap Nasdaq Stocks with Unusual Options Activity: What to Watch

March 16, 2026

Via Barchart.com

Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years ↗

March 11, 2026

Via Benzinga

2 Recession-Resistant Dividend Stocks to Buy Now ↗

March 11, 2026

Via The Motley Fool

What 16 Analyst Ratings Have To Say About Gilead Sciences ↗

March 10, 2026

Via Benzinga

3 Blue-Chip Stocks Built for a Rotating Market ↗

March 08, 2026

Via MarketBeat

These 3 Cash Flow Machines Provide Stability in Uncertain Markets ↗

March 06, 2026

Via MarketBeat

Frequently Asked Questions

Is Gilead Sciences publicly traded?

Yes, Gilead Sciences is publicly traded.

What exchange does Gilead Sciences trade on?

Gilead Sciences trades on the Nasdaq Stock Market

What is the ticker symbol for Gilead Sciences?

The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market

What is the current price of Gilead Sciences?

The current price of Gilead Sciences is 138.99

When was Gilead Sciences last traded?

The last trade of Gilead Sciences was at 04/10/26 04:15 PM ET

What is the market capitalization of Gilead Sciences?

The market capitalization of Gilead Sciences is 174.27B

How many shares of Gilead Sciences are outstanding?

Gilead Sciences has 174B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.